Cargando…
Opportunities for selective reporting of harms in randomized clinical trials: Selection criteria for non-systematic adverse events
BACKGROUND: Adverse events (AEs) in clinical trials may be reported in multiple sources. Different methods for reporting adverse events across trials or across sources for a single trial may produce inconsistent information about the adverse events associated with interventions. METHODS: We compared...
Autores principales: | Mayo-Wilson, Evan, Fusco, Nicole, Hong, Hwanhee, Li, Tianjing, Canner, Joseph K., Dickersin, Kay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6728982/ https://www.ncbi.nlm.nih.gov/pubmed/31488200 http://dx.doi.org/10.1186/s13063-019-3581-3 |
Ejemplares similares
-
Caveat emptor: the combined effects of multiplicity and selective reporting
por: Li, Tianjing, et al.
Publicado: (2018) -
Practical guidance for using multiple data sources in systematic reviews and meta‐analyses (with examples from the MUDS study)
por: Mayo‐Wilson, Evan, et al.
Publicado: (2017) -
Summaries of harms in systematic reviews are unreliable Paper 1: An introduction to research on harms
por: Qureshi, Riaz, et al.
Publicado: (2022) -
Methods to identify and prioritize patient-centered outcomes for use in comparative effectiveness research
por: Mayo-Wilson, Evan, et al.
Publicado: (2018) -
Conducting separate reviews of benefits and harms could improve systematic reviews and meta-analyses
por: Mayo-Wilson, Evan, et al.
Publicado: (2023)